Results 151 to 160 of about 2,965,429 (175)

Cardiac resynchronisation therapy and the role of optimal device utilisation

Netherlands Heart Journal, 2009
Despite established selection criteria, 30 to 40% of patients do not respond to cardiac resynchronisation therapy. By optimising programming of the device response to cardiac resynchronisation, therapy can be improved. (Neth Heart J 2009;17:354-7.)
D J van Veldhuisen, I C van Gelder
exaly   +4 more sources

Optimisation of cardiac resynchronisation therapy device selection guided by cardiac magnetic resonance imaging: Cost-effectiveness analysis.

European Journal of Preventive Cardiology, 2020
BACKGROUND A recent study showed that the presence and characteristics of myocardial scar could independently predict appropriate implantable cardioverter-defibrillator therapies and the risk of sudden cardiac death in patients receiving a cardiac ...
Carlos Crespo, Laura Sampietro-Colom, Beatriz Jáuregui   +2 more
exaly   +2 more sources

Global longitudinal strain as a prognostic marker in cardiac resynchronisation therapy: A systematic review

IJC Heart and Vasculature, 2021
Purpose: Cardiac resynchronisation therapy (CRT) has proven mortality benefits for heart failure patients with moderate to severe systolic left ventricular dysfunction and evidence of a left bundle branch block. Determining responders to this therapy can
Christian R Hamilton-Craig, Stephen Tomlinson, Jonathan Chan   +2 more
exaly   +2 more sources